Clinical Evaluation of (TCAF) Versus (CAF) Combined With Connective Tissue Graft in the Treatment… (NCT07064603) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Clinical Evaluation of (TCAF) Versus (CAF) Combined With Connective Tissue Graft in the Treatment of Multiple RT2 Gingival Recession Sites
22 participantsStarted 2025-10-01
Plain-language summary
the aim of the study is to evaluate the changes in gingival recession depth reduction following, treatment of multiple RT2 recession with tunnel coronal advanced flap in comparison to coronal advanced flap, both combined with connective tissue graft
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients age 18 years or older.
* Multiple adjacent recession defect classified as RT2.
* Patients with healthy systemic condition (Mazzotti et al., 2023).
* An esthetic concern or hypersensitivity associated with GR
* The gingival recessions must have at least 1.5 mm of KTW.
* Presence of an identified CEJ (A step ≤ 1mm of the CEJ level)
Exclusion Criteria:
* Full-mouth plaque and bleeding scores \>20 (O'Leary et al., 1972)
* Patients with active periodontal disease;
* Intake of any medications known to affect gingival homeostasis or to interfere with wound healing
* Pregnancy and nursing women
* Smokers: a contraindication for any plastic periodontal surgery (Khuller, 2009).
* Absence of cervical restorations, crowding or malalignment